Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.007 | 0.8 |
mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |